SAT Platform TechnologyProduct Information
AmpSure®MP-SAT RNA Test
Name AmpSure®MP-SAT RNA Test
Feature:Noninvasive Sampling | Early Diagnosis | Treatment Outcome Evaluation
Detection target


Specimens Requirements

Oropharyngeal Swab, Sputum

Compatible Instruments

AutoSAT, ABI Prism 7300/7500, Strangene Mx 3005, etc.


20 tests | 100 test

Storage and Shelf Life

Reagent A: stored at 2~30℃
Reagent B: -15℃~-30℃
Shelf life: 12 months

Avoid repeated freezing and thawing.



Disease Damage

Mycoplasma Pneumoniae is a Community-Acquired Pneumonia in Children

Mycoplasma pneumoniae pneumonia accounts for approximately 10%-40% of the incidence of CAP in children and is a clinical condition of widespread concern to pediatricians.

Children are immunocompromised and without early treatment are highly susceptible to develop severe MPP, which ultimately leads to death.

Therefore, enhancing the early diagnosis of MPP in children is the key to disease control and treatment.

Use RNA as biomarker can improve detection rate and reduce false positive
Large number of detection targets, allowing for a significant increase in sensitivity
RNA is easily degraded, reducing false positiveion
RNA can be produced upon infection, which is earlier than the appearance of antibodies, so there is no window period for detection
Clinical Application

Assist Clinical Diagnosis of Mycoplasma Pneumoniae Infection

Children: Differential diagnosis of Mycoplasma pneumoniae pneumonia and other respiratory tract infections, etc.

Adults: For early diagnosis of Mycoplasma pneumoniae pneumonia in adults

Contact Information



Address:Block A, building 15, NO.528 Ruiqing Road, East District, Zhangjiang High Tech Park, Shanghai, P.R .China

Copyright © Shanghai Rendu Biotechnology Co.,Ltd.